# Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)

> **NCT01988571** · PHASE2 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 279 (actual)

## Conditions studied

- Breast Cancer
- Lymphoma

## Interventions

- **DRUG:** Atorvastatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01988571
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02-01
- **Primary completion:** 2020-09-24
- **Final completion:** 2020-09-24
- **Target enrollment:** 279 (ACTUAL)
- **Last updated:** 2022-01-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01988571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01988571, "Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01988571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*